Press Releases

Hong Kong Sanatorium & Hospital to Acquire Three Radixact™ Systems SUNNYVALE, Calif., December 21, 2016 – Accuray Incorporated (NASDAQ: ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital (HKSH) for the acquisition of three RadixactTM Systems that will provide clinicians and their patients with access to the newest advanced radiation therapy. Of the three Radixact Systems, two will replace existing TomoTherapy® Systems and one will be installed in a new bunker. The agreement also includes an upgrade of HKSH’s existing CyberKnife® M6™ System to include the latest features for motion management and treatment efficiency, and was entered into backlog during Accuray’s second fiscal quarter which ends December 31, 2016. Read More »
First Cancer Patients in the World Treated with the Smart, New Accuray Radixact™ System SUNNYVALE, Calif., December 8, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that leading hospitals in Europe and the United States are now treating patients with the new Radixact™ Treatment Delivery System, fully integrated with the new Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. The first patient treatment in the world was administered at the University Hospital Brussels (UZ Brussel) in Belgium and in the United States at Froedtert & the Medical College of Wisconsin Froedtert Hospital in Milwaukee, Wisconsin, part of the Froedtert & MCW Cancer Network. Read More »
Accuray to Participate in the Citi 2016 Global Healthcare Conference SUNNYVALE, Calif., November 21, 2016-- Accuray Incorporated (Nasdaq: ARAY), announced today that it will participate in the Citi 2016 Global Healthcare Conference on Thursday, December 8, 2016 in New York. Kevin Waters, Senior Vice President and Chief Financial Officer, will meet with investors one-on-one at the conference. Read More »
Accuray Reports Financial Results for First Quarter and Affirms Full Year Fiscal 2017 Guidance SUNNYVALE, Calif., October 27, 2016 – Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the 2017 fiscal first quarter ended September 30, 2016. Read More »
Accuray to report fiscal 2017 first quarter financial results on October 27, 2016 SUNNYVALE, CALIF., October 6, 2016—Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal first quarter ended September 30, 2016 on Thursday, October 27, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. Read More »
Prospective, Multi-Institutional Study Shows Five Treatments with the CyberKnife® System Provide Excellent Disease Control for Prostate Cancer Patients SUNNYVALE, Calif., September 27, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, 21 center study showed 97 percent of low- and intermediate-risk prostate cancer patients had excellent cancer control five years after receiving stereotactic body radiation therapy (SBRT) administered with the CyberKnife® System. The treatment was extremely well-tolerated; serious side effects were uncommon (less than two percent) after more than five years of follow-up. The study was presented during an oral session yesterday at the American Society for Radiation Oncology (ASTRO) 58th Annual Meeting and was one of 15 to be selected out of thousands of abstracts for presentation during an ASTRO press conference, scheduled for today. Read More »
Accuray to Unveil New Technology at the ASTRO 2016 Annual Meeting SUNNYVALE, Calif., September 22, 2016 – New data on the Accuray (NASDAQ: ARAY) CyberKnife® and TomoTherapy® Systems will be shared by leading radiation oncology practitioners, and the Company’s new, innovative radiation therapy treatment delivery system, the Radixact™ System, and treatment planning software, will be unveiled at the 2016 ASTRO (American Society for Radiation Oncology) Annual Meeting in Boston, Massachusetts, September 25 – 28, 2016. ASTRO is the world's most important meeting for the radiation oncology community with more than 11,000 attendees each year. Meeting attendees are invited to attend the U.S. unveiling of the Radixact System at Accuray booth #2009 on Sunday, September 25 at 11:15 am ET. Read More »
Accuray to Participate in the Morgan Stanley Global Healthcare Conference 2016 SUNNYVALE, Calif., September 6, 2016-- Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 14, 2016 at 8:45 a.m. ET. Read More »

Pages